CPT® Code 91311

Deleted

1. Indications

The CPT® Code 91311 is indicated for the administration of the COVID-19 vaccine in specific patient populations. The following conditions and circumstances warrant the use of this vaccine:

• Protection Against COVID-19 The vaccine is intended to provide immunity against the SARS-CoV-2 virus, which causes coronavirus disease (COVID-19).
• Pediatric Vaccination Specifically indicated for young children aged 6 months through 5 years, ensuring that this vulnerable population receives protection against severe illness from COVID-19.

2. Procedure

The administration of the COVID-19 vaccine under CPT® Code 91311 involves several key procedural steps that ensure the vaccine is delivered safely and effectively. Each step is crucial for the successful immunization of the patient.

• Step 1: Preparation of the Vaccine Prior to administration, the vaccine must be prepared according to the manufacturer's guidelines. This includes ensuring that the vaccine is at the appropriate temperature and that it is mixed properly if required. The healthcare provider should verify the vaccine's expiration date and ensure that it is the correct formulation for the intended patient population.
• Step 2: Patient Assessment Before administering the vaccine, the healthcare provider should conduct a thorough assessment of the patient’s medical history, including any previous allergic reactions to vaccines, current medications, and overall health status. This assessment helps to identify any contraindications to vaccination.
• Step 3: Administration of the Vaccine The vaccine is administered via intramuscular injection, typically in the deltoid muscle of the upper arm for older children and in the thigh for infants and toddlers. The provider should use a sterile technique, ensuring that the injection site is clean and free from contaminants. The vaccine is delivered in a dosage of 25 mcg per 0.25 mL.
• Step 4: Post-Administration Monitoring After the vaccine is administered, the patient should be monitored for a short period to observe for any immediate adverse reactions. This monitoring typically lasts for 15 to 30 minutes, during which the healthcare provider can address any concerns and provide guidance on potential side effects.

3. Post-Procedure

Following the administration of the COVID-19 vaccine, patients may experience mild side effects, which are common and typically resolve within a few days. These may include soreness at the injection site, fatigue, headache, muscle pain, chills, fever, or nausea. Parents and guardians should be informed about these potential reactions and advised on how to manage them, such as using over-the-counter pain relievers if necessary. It is also important to schedule the second dose of the vaccine as per the recommended vaccination schedule to ensure full immunization. Patients should be encouraged to report any unusual or severe reactions to their healthcare provider. Additionally, ongoing education about the importance of vaccination and adherence to public health guidelines should be provided to ensure community protection against COVID-19.